Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis-Reference-Cited by-同舟云学术

Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis

Published:2018-07-05 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Rognoni Carla^ORCID,Ciani Oriana,Sommariva Silvia,Bargellini Irene,Bhoori Sherrie,Cioni Roberto,Facciorusso Antonio,Golfieri Rita,Gramenzi Annagiulia,Mazzaferro Vincenzo,Mosconi Cristina,Ponziani Francesca,Sacco Rodolfo,Trevisani Franco,Tarricone Rosanna

Funder

ASBM srl

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4636-7.pdf

Reference32 articles.

1. http://globocan.iarc.fr/old/FactSheets/cancers/liver-new.asp (Accessed 21 May 2018).

2. ESMO, Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, European Society for Medical Oncology 2010. Available from http://www.esmo.org (Accessed 21 May 2018).

3. Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.